TransMedics’ OCS Technology Sees Success in Heart Transplant  Nasdaq

TransMedics’ OCS Technology Sees Success in Heart Transplant  Yahoo Finance

Buttigieg Says He Won’t Stop Closed-Door Fundraisers With Billionaires  Newsweek

Posttransplantation Cyclophosphamide-Based Regimen Found More Effective Than Conventional Immunosuppression in Lowering Risk of GVHD  Cancer Therapy Advisor

Fedex truck runs off I-95, strikes a sign  8News

Precision BioSciences Presents Updated Interim Clinical Data at the ASH Annual Meeting from Relapsed / Refractory NHL and B-ALL Patients Treated at Dose Levels 1 & 2 in the Ongoing Phase 1/2a Clinical Trial of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate  GlobeNewswire